Company Adds Another CBG Product To Its GO Nutraceutical Branded Line Of “Cannabis 2.0” Products
Waterloo, Ontario, May 11, 2020: SponsorsOne Inc. (CSE:SPO), (Frankfurt: 5SO), (OTC:SPONF), a company that utilizes its proprietary platform that combines digital marketing, wholesale and retail distribution, branding and operational & funding capital, giving it a competitive first mover advantage in rapidly building, launching and selling proprietary brands focused in the craft Alcohol, Functional Beverage and Cannabis Sectors, today announced that It has introduced another innovative CBG product, under the marketing management agreement with GO Nutraceutical’s branded line of “Cannabis 2.0” products.
The company, which recently launched a line of flavored, chewable tablets delivering a 20mg dose of CBG, has now added a CBG sublingual dissolving tablet that delivers 10mg in a very small 6mm size also produced by GO Nutraceuticals. Sublingual dissolving tablets are placed under the tongue triggering much higher bioavailability which results in faster absorption into the body.
As with the chewable product, this will be sold direct to consumer through GO Nutraceuticals’ online store and through SPO’s wholesale and retail distribution channel leveraging the company’s rapidly expanding influencer network to build market awareness.
Myles Bartholomew, CEO of SponsorsOne, said: “Oral dissolving CBG tablets are one of the more unique offerings in our solid oral dose line. At 10mg and only 6mm round, the tiny size tablet melts perfectly in the mouth without the need for digestion. Oral dissolving tablets are new to the cannabis industry, but they are showing great potential. The product is easy and enjoyable to consume, the deliveries are small, and it tastes great. But it is not only our delivery system that is the key here, it is fact that we are utilizing CBG, which as we have said before, has been shown to possess enormous therapeutic promise, and has been called the holy grail of cannabinoids. We have taken the knowledge of the pharmaceutical industry and applied it to natural extracts to create the next innovative wave of cannabis deliveries. We believe this will help us separate the company from others in the market and will increase revenues and bring value to our shareholders.”
About GO Nutraceuticals Inc.
GO and its team have spent the last 5 years developing an all-natural single step infusion process to combine certain of the healthiest botanicals into a raw – whole plant oil product. No chemicals, no heat, no alteration of the natural plant creates an oil “The way mother nature intended”. By preserving the acid (CBDA, CBGA, THCA) contained in the hemp plant, maximum efficacy is experienced as the body’s endocannabinoid system can absorb all 120 cannabinoids in their natural state. The Entourage Effect is in full force, where all of the cannabinoid categories interact for maximum health benefits. GO has a complete 30 ml bottle product line with three concentrations (250, 500 and 1000mg) and by infusing botanicals providing specific known health benefits has created, GO Ease, GO Dream, Go Meditate, GO Energize, GO Relax, GO Rejuvenate and GO Heal. GO will launch nationally in the USA in 2020 and plans to expand its operations and product offering internationally in 2021.
About SponsorsOne Inc.:
SponsorsOne is the leader in the next evolution of digital marketing through micro-influence, storytelling and digital-commerce with the SponsorCoin platform and its highly scalable – smart contract based digital- currency. Combined, this allows brands to build and manage exclusive and highly engaged communities of influencers (from pro to micro-influencers) within the social realm. The SponsorCoin platform provides for data-driven marketing campaigns that will change the way brands connect with their customers. SponsorCoin is a tool for brands to inspire real movements around their products and services in which their most valuable customers become their best salespeople, producing far higher ROI than current social media advertising methods.
ON BEHALF OF THE BOARD
Gary Bartholomew, Executive Chairman
To learn more or inquire please visit www.sponsorsone.com/
The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this Press Release.
FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements and information that are based on the beliefs of management and reflect the Company’s current expectations. When used in this news release, the words “estimate”, “project”, “belief”, “anticipate”, “intend”, “expect”, “plan”, “predict”, “may” or “should” and the negative of these words or such variations thereon or comparable terminology, are intended to identify forward-looking statements and information. Such statements and information reflect the current view of the Company with respect to risks and uncertainties that may cause actual results to differ materially from those contemplated in those forward-looking statements and information.
By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following risks:
- risks associated with marketing and sale of securities
- the need for additional financing requirements and access to capital, reliance on key personnel
- the potential for conflicts of interest among certain officers or directors with certain other projects
- the volatility of the volume and price of the Common Shares, the failure of the business strategy, the integrity of the Company’s patents and proprietary intellectual property and competition.
The Company cautions that the foregoing list of risk factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. When relying on the Company’s forward-looking statements and information to make decisions, investors and others should carefully consider the foregoing factors, and other uncertainties and potential events, including the risk factors, set out in the Company’s Listing Statement. The Company has assumed a certain progression, which may not be realized. It has also assumed that the material factors referred to above will not cause such forward-looking statements and information to differ materially from actual results or events.
THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF THE COMPANY AS OF THE DATE OF THIS NEWS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE SECURITIES LEGISLATION.
Recent Comments